"We are a private, Cullman Alabama based provider of clinical trials. It is our aim to improve treatments and to provide advancements in Primary Care and Multi-Specialties that result in a better future for all patients, providers, and sponsors"

During the past decade, Cullman Clinical Research, Inc conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cullman Clinical Research, Inc" are "Respiratory Tract Infection" (2 trials). Many other conditions were trialed in "Cullman Clinical Research, Inc" in a lesser frequency.

Most popular intervention types in "Cullman Clinical Research, Inc" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "RSV vaccine" (1 trials) and "RSVpreF" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cullman Clinical Research, Inc" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Cullman Clinical Research, Inc". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Cullman Clinical Research, Inc, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cullman Clinical Research, Inc, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".